| Value | ₹71.35 Cr |
|---|
BSE filing, NSE: KMCSHIL. Summary written from the filing by ALFA Finder's alert engine.
KMC Speciality Hospitals (India) Ltd: key numbers
- Share price
- ₹148.50
- Market cap
- ₹2,422 Cr
- Revenue (annual)
- ₹305.8 Cr
- Net profit (annual)
- ₹46.73 Cr
- P/E (TTM)
- 43.4×Sector 52.8×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 0.03%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from KMC Speciality Hospitals (India) Ltd
All →KMC Speciality Hospitals (India) Other Announcement
The filing reports the quarterly shareholding pattern for KMC Speciality Hospitals (India) Ltd as of September 30, 2026. It includes disclosures regarding indirect promoter encumbrances.
KMC Speciality Hospitals (India) Share Pledge
KMC Speciality Hospitals (India) Ltd submitted a revised disclosure under SEBI (SAST) Regulations regarding the encumbrance of shares by its promoter group to the BSE.
KMC Speciality Hospitals (India) Annual General Meeting
KMC Speciality Hospitals (India) Limited held its 43rd Annual General Meeting on September 28, 2026. The meeting transacted ordinary and special business as per the notice.
KMC Speciality Hospitals (India) Share Pledge
Promoter Sri Kauvery Medical Care (India) Ltd has created an encumbrance on 27,41,435 equity shares of KMC Speciality Hospitals (India) Ltd.
KMC Speciality Hospitals (India) Annual Report
KMC Speciality Hospitals (India) Limited has filed its Annual Report and notice for the 43rd Annual General Meeting scheduled for September 28, 2026.
KMC Speciality Hospitals (India) Annual General Meeting
KMC Speciality Hospitals (India) Ltd has scheduled its 43rd Annual General Meeting for September 28, 2026, via video conferencing to transact special business.
Other debt & borrowing announcements
All →Neogen Chemicals Debt & Borrowing: ₹500 Cr
Neogen Chemicals approved in-principle a Rs 500 Crore corporate guarantee for Neogen Morita's borrowings, subject to shareholder approval. The company reports no adverse impact.
- Value
- ₹500.0 Cr
Satin Creditcare Network Debt & Borrowing: ₹1.83 Cr
Satin Creditcare paid Rs.1.83 Crore quarterly interest on its 10.40% April 2027 NCDs on 31 October 2026. The payment fulfils an existing debt obligation.
- Value
- ₹1.83 Cr
AAA Technologies Debt & Borrowing: ₹6 Cr
AAA Technologies approved an inter-corporate loan of up to Rs.6 Crore to Transaction Solutions International at 12% interest. Repayable on demand; share-pledge security is proposed.
- Value
- ₹6.00 Cr
Spandana Sphoorty Financial Debt & Borrowing: ₹12.5 Cr
Spandana Sphoorty partially redeemed Rs 12.50 Crore of its listed secured NCDs on 31 October 2026 by face-value redemption. Rs 200 Crore remains outstanding.
- Value
- ₹12.50 Cr
Spandana Sphoorty Financial Debt & Borrowing: ₹2.71 Cr
Spandana Sphoorty paid monthly interest of Rs 2.71 Crore across two listed secured NCD series on 30 October 2026, on time. Series-wise amounts were Rs 2.01 Crore and Rs 0.70 Crore.
- Value
- ₹2.71 Cr
Industrial Investment Trust Debt & Borrowing: ₹200 Cr
Industrial Investment Trust's board approved borrowing up to Rs. 200 Crore from banks, NBFCs and other lenders, within the Rs. 1,000 Crore shareholder limit. The enabling approval names no specific lender yet.
- Value
- ₹200.0 Cr